维普中文期刊产品整合服务
12篇 您的检索式:作者名="Attar EC"
    题名 作者 年代 出处 被引量
1Addition of bortezomib (Velcade) to AML induction chemotherapy is well tolerated and results in a high complete remission rate 显示文摘Attar EC De Angelo D J Sirulnik A 2005Blood2005,106,11:1
2Phase I and pharmacokinetic study of bortezomib in combination with idarubiein and eytarabine in patients with acute myelogenous leukemia显示文摘Attar EC De Angelo DJ Supko JG 2008Clin Cancer Res2008,14,5:1
3GAS6 induces Axl - mediated chemotaxis of vascular smooth muscle cells 显示文摘Fridell YW Villa J Jr Attar EC 1998J Biol Chem1998,273,12:1
4Bortezomib added to dannorubi- cin and cytarabine during induction therapy and to intermediate-dose cvtarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502 显示文摘Attar EC Johnson JL Amrein PC 2013J Clin Oncol2013,31,7:1
5Phase Ⅰ and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia显示文摘Attar EC De Angelo DJ Supko JG 2008Clin Cancer Res2008,14,5:1
6Regulation of hematopoietic stem cell growth 显示文摘Attar EC Scadden DT 2004Leukemia2004,18,11:1
7Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelo- dysplastic syndromes (MDS) and acute myeloid leukemia (AML) 显示文摘Attar EC Amrein PC Fraser JW 2013Leuk Res2013,37,9:1
8Phase 1 and pharmacokinetic study of Bortezomib in combination with Idarubicin and cytarabine in patients with acute myelogenous leukemia显示文摘Attar EC DeAngelo DJ Supko JG 0,,05:1
9Phase I and pharmaco- kinetic study of bortezomib in combination with idarubicin and cyt- arabine in patients with acute myelogenuus leukemia 显示文摘Attar EC De Angelo DJ Supko JG 2008Clin Cancer Res2008,14,5:1
10Gaso induces Axl-mediated chemotaxis of vascular smooth muscle cells 显示文摘Fridell YW Villa J Attar EC 1998J Biol Chem1998,273,12:1
11Response to dasatinib in patients w ith relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma(CLL/SLL)correlates w ith p-Lyn and p-Syk显示文摘Amrein PC Attar EC Takvorian T 2010Blood(ASH Annual M eeting Abstracts)2010,116,:1
12Addition of bortezomib(Velcade) to AML induction chemotherapy is well tolerated and results in s high complete remission rate显示文摘Attar EC DeAngelo DJ Sirulnik A 2005Blood2005,106,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费